Mental symptoms in Parkinsonian patients treated with L-dopa.
about
Visual hallucinations in the elderly associated with the use of levodopaNovelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area.Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.Does levodopa alter depression and psychopathology in Parkinsonism patients?Management of parkinson's disease--combined therapy with levodopa and thalamotomy.Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent.Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease.Atypical antipsychotics in Parkinson-sensitive populations.Monoamine reuptake inhibitors in Parkinson's disease.Psychiatric aspects in Parkinsonism treated with L-dopa.Genetic influences on adolescent sexual behavior: Why genes matter for environmentally oriented researchers.Behavioral complications of drug treatment of Parkinson's disease.The role of neurotransmitters in the development of Parkinson's disease-related psychosis.Adverse psychiatric reactions to modern medication.Apomorphine and psychopathology.Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.Side effects from levodopa.Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.Monamine oxidase inhibitors and brain monamines in clinical conditions.Depression in the elderly. II. Possible drug etiologies; differential diagnostic criteria.A drug naive parkinsonian patient successfully treated with weak electromagnetic fields.An L-dopa paradox: bipolar behavioral alterations.Psychiatric aspects of L-dopa therapy of Parkinson's disease.
P2860
Q28355598-344062F9-B31C-4032-8A4A-DEE4FC992F25Q32027963-AAD89DB9-F146-480C-890B-7C8DED05F5CBQ33619721-EC9E9A5D-C948-4330-9481-3D3B0AE12337Q33756784-B45A0806-A934-4B53-8EFB-C0B1DAAF330DQ33824385-D65EBF75-410E-4EA6-8DFA-E7455044F5F7Q33884378-27205020-F4B1-4D47-BC21-BABCF76D92D1Q33897932-32466620-0F8D-4DC5-A672-12E6DF206FC5Q34341299-23C942F7-B22B-40A2-871E-E239390613FBQ34851726-88A54869-50E9-4095-9FD6-9D1BBF92162CQ35165280-7DB51E03-9CF2-44A3-A9E9-D704608CAEF2Q37079436-CDA04088-9C32-4462-8064-93203066B5CCQ37484502-72D9EEED-B7D8-4708-BD56-36C5D1D1A8C7Q37771070-64756847-05F1-4C07-B5A1-10C4617A7CA3Q38649501-43B175D9-0B26-4368-AB67-E161BC3A3512Q40085283-EEF4FC1D-8A6B-417F-AB11-3AFEB6C078DEQ41858388-EA5D9DBA-C5BF-471F-8D91-E0E1AEE637C8Q42232842-2DFB6928-C0C0-4D27-B454-4E5FD4911440Q42425937-7228DF3D-C625-4D14-81F5-C874796B84CAQ42541980-2247FD3B-65AC-4603-B2D8-8230BABB91F9Q42921966-E1815D92-B7E7-4E6F-91B0-3F0C8EA7BA51Q45013188-78017F09-FF09-4744-906F-9C405E5F7985Q48831449-EAAA6159-D925-49E4-B182-DA5ABF264316Q51316036-3BF8C81D-0867-4622-AC98-9104B7A8F07FQ52121364-1A92FC7E-0FAB-40BC-8EC7-DD37DD35AE76
P2860
Mental symptoms in Parkinsonian patients treated with L-dopa.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Mental symptoms in Parkinsonian patients treated with L-dopa.
@en
Mental symptoms in Parkinsonian patients treated with L-dopa.
@nl
type
label
Mental symptoms in Parkinsonian patients treated with L-dopa.
@en
Mental symptoms in Parkinsonian patients treated with L-dopa.
@nl
prefLabel
Mental symptoms in Parkinsonian patients treated with L-dopa.
@en
Mental symptoms in Parkinsonian patients treated with L-dopa.
@nl
P1433
P1476
Mental symptoms in Parkinsonian patients treated with L-dopa.
@en
P2093
P304
P356
10.1016/S0140-6736(70)92535-3
P407
P577
1970-07-01T00:00:00Z